HSA - MIT
καρκίνο | ellines.com
Ioannis Zervantonakis - Assistant Professor - University of Pittsburgh | LinkedIn
Zervantonakis
HBA Mentoring Program - Mentors | Hellenic Bioscientific Association of the USA
Reversing Drug Resistance in Breast Cancer | Regenerative Medicine at the McGowan Institute
Podcast: Dr. Ioannis Zervantonakis Discusses the Microenvironment of Tumors | Regenerative Medicine at the McGowan Institute
Elin NYMAN | PostDoc Position | PhD | Linköping University, Linköping | LiU | Department of Biomedical Engineering
Ioannis Zervantonakis | United States | Zervantonakis lab
Congrats to recent recipients of postdoctoral fellowships! (Part 1) | Cell Biology
Personal Website of Ioannis (Yannis) Zervantonakis, Ph.D. - Home
Zervantonakis
Ioannis Zervantonakis | Harvard Medical School - Academia.edu
Zervantonakis
computational modeling Archives | Regenerative Medicine Today
Ioannis Zervantonakis | The Brugge Lab
Microfluidic tumor-vascular interface model. (A) Endothelial channel... | Download Scientific Diagram
SoundCloud - Hear the world's sounds
Ioannis (Yannis) Zervantonakis (@zervanto) | Twitter
Faculty | Integrative Systems Biology | University of Pittsburgh | University of Pittsburgh
Ioannis (Yannis) Zervantonakis (@zervanto) | Twitter
Ioannis Zervantonakis - Assistant Professor - University of Pittsburgh | LinkedIn
Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines,Cancer Cell - X-MOL
Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response | Nature Communications
Ioannis Zervantonakis | United States | Zervantonakis lab
Tan INCE | MDPhD | University of Miami Miller School of Medicine, Florida | UM | Sylvester Comprehensive Cancer Center - Page 2
Zervantonakis
BRAF and AXL oncogenes drive RIPK3 expression loss in cancer
Muranen Lab
